Register entry

Curia New York, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
39
Labeller names
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

39

39 active NDC listings: 39 bulk ingredient. By marketing category: BULK INGREDIENT 27, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 12.

Dosage formNDCs
powder39
RouteNDCs
Labeller name on the listingNDCs
curia new york, inc.37
curia new york, inc2
Catalogue

Marketed products

39
BrandGeneric nameForm / routeNDC
-Alogliptinpowder65392-2813BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Ambenonium Chloridepowder65392-1002BULK INGREDIENT
-Amphetamine Aspratate Monohydratepowder65392-0117BULK INGREDIENT
-Amphetamine Sulfatepowder65392-0110BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Belinostatpowder65392-2509BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Cantharidinpowder65392-3416BULK INGREDIENT
-Cetalkonium Chloridepowder65392-1201BULK INGREDIENT
-Dextroamphetamine Saccharatepowder65392-0115BULK INGREDIENT
-Dextroamphetamine Sulfatepowder65392-0114BULK INGREDIENT
-Diatrizoate Megluminepowder65392-1314BULK INGREDIENT
-Diatrizoate Sodiumpowder65392-1701BULK INGREDIENT
-Echothiophate Iodidepowder65392-1402BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Enzalutamidepowder65392-2209BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Epinephrinepowder65392-1405BULK INGREDIENT
-Gamma Hydroxybutyric Acidpowder65392-3417BULK INGREDIENT
-Lifitegrastpowder65392-2803BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Lisdexamfetamine Dimesylatepowder65392-0118BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-MGL-3196powder65392-3203BULK INGREDIENT
-Mafenide Acetatepowder65392-2801BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Mangafodipir Trisodiumpowder65392-2204BULK INGREDIENT
-Meperidine Hydrochloridepowder65392-0923BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Metolazonepowder65392-2201BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Milrinonepowder65392-2202BULK INGREDIENT
-Norepinephrine Bitartratepowder65392-2301BULK INGREDIENT
-Pentobarbital Sodiumpowder65392-0227BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Pralatrexatepowder65392-2510BULK INGREDIENT
-Pralidoxime Chloridepowder65392-2503BULK INGREDIENT
-Primaquine Phosphatepowder65392-2502BULK INGREDIENT
-Racepinephrine Hydrochloridepowder65392-2701BULK INGREDIENT
-SNDX-5613powder65392-3402BULK INGREDIENT
-SNDX-5613powder65392-3415BULK INGREDIENT
-Sodium Thiosulfate Pentahydratepowder65392-3403BULK INGREDIENT
-Tedizolid Phosphatepowder65392-2912BULK INGREDIENT
-Trientine Hydrochloridepowder65392-2901BULK INGREDIENT
-Vorinostat Coarsepowder65392-3101BULK INGREDIENT
-Vorinostat Finepowder65392-3102BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-brigatinibpowder65392-3311BULK INGREDIENT
-dexmethylphenidate hydrochloridepowder65392-3418BULK INGREDIENT
-palovarotenepowder65392-3414BULK INGREDIENT
Enquiry

Common questions

Is Curia New York, Inc. FDA approved?
Curia New York, Inc. holds no registered establishment of its own; 39 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Curia New York, Inc. make?
39 products are listed under Curia New York, Inc. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.